药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cryptenamine
Indacaterol
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Indacaterol.
Cryptenamine
Lidoflazine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lidoflazine.
Cryptenamine
Bencyclane
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bencyclane.
Cryptenamine
Gallopamil
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Gallopamil.
Cryptenamine
Aranidipine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Aranidipine.
Cryptenamine
Pinaverium
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Pinaverium.
Cryptenamine
Levomenthol
The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Desipramine.
Cryptenamine
Niguldipine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Niguldipine.
Cryptenamine
Lacidipine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lacidipine.
Cryptenamine
Lapatinib
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lapatinib.
Cryptenamine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Desipramine.
Cryptenamine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Desipramine.
Cryptenamine
Lorajmine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lorajmine.
Cryptenamine
Prajmaline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Prajmaline.
Cryptenamine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Cibenzoline.
Cryptenamine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Pilsicainide.
Cryptenamine
Givinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Givinostat.
Cryptenamine
Temefos
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Temefos.
Cryptenamine
CUDC-907
The risk or severity of QTc prolongation can be increased when Desipramine is combined with CUDC-907.
Cryptenamine
Bilastine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bilastine.